Valion Bio (VBIO) Cash & Current Investments (2021 - 2026)

Valion Bio's Cash & Current Investments history runs 5 years deep, the most recent figure standing at $12.6 million for Q4 2025.

• In Q4 2025, Cash & Current Investments rose 529.37% year-over-year to $12.6 million; the TTM figure through Dec 2025 stood at $12.6 million (up 529.37% YoY), while the FY2025 annual figure was $12.6 million, up 529.37% from the prior year.
• Cash & Current Investments for Q4 2025 stood at $12.6 million, up from $3.4 million in the prior quarter.
• The five-year high for Cash & Current Investments was $12.8 million in Q1 2021, with the low at $669000.0 in Q1 2025.
• The 5-year median for Cash & Current Investments is $3.5 million (2022), against an average of $5.4 million.
• The sharpest annual moves came in 2023 and 2025: Cash & Current Investments plunged 75.88% in 2023, then surged 529.37% in 2025.
• Valion Bio's Cash & Current Investments stood at $12.8 million in 2021, then plunged by 72.51% to $3.5 million in 2022, then slipped by 7.79% to $3.2 million in 2023, then slumped by 38.27% to $2.0 million in 2024, then soared by 529.37% to $12.6 million in 2025.
• Business Quant data shows VBIO's Cash & Current Investments at $12.6 million in Q4 2025, $3.4 million in Q3 2025, and $1.2 million in Q2 2025.